Literature DB >> 29589268

Changes in Trace Elements During Early Stages of Chronic Kidney Disease in Type 2 Diabetic Patients.

Ching-Chiang Lin1,2, Ching-Tang Shih3, Chien-Hung Lee4, Yeou-Lih Huang5,6,7.   

Abstract

Trace elements can influence glucose metabolism and be related to oxidative stress in type 2 diabetes mellitus. Moreover, trace elements play important roles in the nephrotic complications of these patients. Nevertheless, few investigations have been made into the changes in the levels of trace elements in diabetic patients at various stages of chronic kidney disease (CKD). The aims of this present study were to determine the levels of some important trace elements in diabetic patients during the early stages of CKD and to identify the relationship between these elements and CKD progression in type 2 diabetic patients. One hundred and forty-eight type 2 diabetic patients with chronic kidney diseases were recruited into this study. The subjects were grouped into four stages (1, 2, 3a, 3b) of CKD, according to their urine protein levels and estimated glomerular filtration rates (eGFRs). The levels of serum zinc and iron exhibited a statistically significant decreasing trend (P trend = 0.032 and 0.047, respectively) from stage 1 to stage 3b after adjustment for age, gender, smoking, alcohol consumption, education, hypertension, and body mass index. The other tested elements, including copper, magnesium, selenium, chromium, and manganese, did not display any significant trends upon proceeding from stage 1 to stage 3b. Thus, serum zinc and iron appear to be useful markers when evaluating the early progression of CKD in type 2 diabetic patients.

Entities:  

Keywords:  Chromium; Diabetic chronic kidney disease (CKD); Magnesium; Selenium; Type 2 diabetes; Zinc

Mesh:

Substances:

Year:  2018        PMID: 29589268     DOI: 10.1007/s12011-018-1314-1

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  4 in total

Review 1.  Role of Zinc in Diabetic Kidney Disease.

Authors:  Guido Gembillo; Luca Visconti; Alfio Edoardo Giuffrida; Vincenzo Labbozzetta; Luigi Peritore; Antonella Lipari; Vincenzo Calabrese; Giorgina Barbara Piccoli; Massimo Torreggiani; Rossella Siligato; Domenico Santoro
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

2.  The association of serum magnesium and chronic kidney disease: a two-sample mendelian randomization study of European descent.

Authors:  Chenyang Hou; Yun Wang; Xinxia Sui; Wei Xin; Qingzhi Hou; Jihu Yi; Huichen Yao; Weihua Liu; Zhiyuan Yu; Lichuan Xia; Qing Guo
Journal:  Eur J Clin Nutr       Date:  2022-03-08       Impact factor: 4.884

3.  A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations.

Authors:  Mamoru Sakurai; Junko Sasaki; Hirotsugu Suwanai; Jumpei Shikuma; Rokuro Ito; Masato Odawara; Takashi Miwa; Ryo Suzuki
Journal:  Diabetol Int       Date:  2021-07-10

4.  Micronutrients and Renal Outcomes: A Prospective Cohort Study.

Authors:  Chun-Yu Chen; Chun-Hui Chiu; I-Wen Wu; Heng-Jung Hsu; Yih-Ting Chen; Cheng-Kai Hsu; Heng-Chih Pan; Chin-Chan Lee; Chiao-Yin Sun
Journal:  Nutrients       Date:  2022-07-26       Impact factor: 6.706

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.